CD8A and neoplasm: This study also found that PD-1/PD-L1 expression on TAMs and CTLA-4 expression on CD8+ T cells was increased in the presence of CSF-1/CSF-1R blockade, and the combination of PD-1 or CTLA-4 antagonists resulted in more significant tumor regression (103).